Company Financials

Hangzhou Tigermed Consulting Co. Ltd Financials

Renminbi

business Hangzhou Tigermed Consulting Co. Ltd Company Profile

Main Stock Listing

SZSE: 300347

Market Capitalization CN¥44.26 Billion as of July 1, 2025

Market Cap History

Valuations Metrics as of Jul. 4, 2025

Trailing PE 138.77
Forward PE 25.89
Price to Sales TTM CN¥6.81
Price to Book MRQ CN¥2.25
Enterprise to Revenue 7.74
Enterprise to EBITDA 47.58

Financial Reports as of Mar. 31, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-03-31
Profit Margin 5.16%
Operating Margin 11.27%
Return on Assets TTM 1.80%
Return on Equity TTM 1.01%

Income Statement

Revenue TTM CN¥6,507,059,200
Revenue per Share TTM CN¥7.54
Quarterly Revenue Growth -5.80%
Gross Profit TTM CN¥2,085,886,464
EBITDA CN¥1,208,798,214
Net Income to Common TTM CN¥335,540,224
Diluted EPS TTM CN¥0.39
Quarterly Earnings Growth YoY -29.60%

Balance Sheet

Total Cash MRQ CN¥1,675,267,456
Total Cash per Share MRQ CN¥1.96
Total Debt MRQ CN¥
Total Debt to Equity MRQ 12.76
Current Ratio MRQ 1.62
Book Value per Share MRQ CN¥24.01

Cash Flow

Operating Cash Flow TTM CN¥1,150,732,032
Levered Free Cash Flow TTM CN¥482,271,168

300347 Stock Info as of Jul. 4, 2025

Stock Statistics

Shares Outstanding 864,948,570
Float Shares 616,010,286
Avg 10 Volume 9,537,592
Avg 30 Volume None
Shares Short None
Short Ratio
Short % of Shares %
% Held by Insiders 32.38%
% Held by Institutions 25.95%

Stock Price Summary

Beta 0.78
Fifty Two Week Low CN¥41.61
Fifty Two Week High CN¥82.79
Fifty Two Week Change 8.92%
Day 50 MA CN¥47.98
Day 200 MA CN¥54.75

Dividends and Splits

Forward Annual Dividend Rate CN¥1.20
Forward Annual Dividend Yield 2.23%
Trailing Annual Dividend Rate CN¥0.30
Trailing Annual Dividend Yield 0.56%
Payout Ratio 145.64%
Dividend Date
Ex Dividend Date 2025-06-17
Last Split Factor
Last Split Date 2019-07-01